Thrombolysis: The development of unit guidelines

Intensive and Critical Care Nursing

Volumn 13, Issue 1, 1997, Pages 30-41

  Kynman, Gary ^a  

^a General Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ALGORITHM; DECISION TREE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; INTENSIVE CARE; METHODOLOGY; PATIENT SELECTION; PRACTICE GUIDELINE; REVIEW; STANDARD;

ALGORITHMS; CRITICAL CARE; DECISION TREES; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; PATIENT SELECTION; PRACTICE GUIDELINES; THROMBOLYTIC THERAPY;

EID: 0031062747     PISSN: 09643397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0964-3397(97)80703-3     Document Type: Article

References (17)

1. Agnelli G 1995 Thrombolytic and antithrombotic treatment in myocardial infarction: main achievements and future perspectives. International Journal of Cardiology 49 Suppl: S77-87
2. Bell W R, Meek A G 1979 Guidelines for the use of thrombolytic agents. New England Journal of Medicine 301. 1266-1270 cited in. Dollery C (ed) Streptokinase Therapeutic drugs, 1993 Churchill Livingstone, Edinburgh
3. Bell W R, Meek A G 1979 Guidelines for the use of thrombolytic agents. New England Journal of Medicine 301. 1266-1270 cited in. Dollery C (ed) Streptokinase Therapeutic drugs, 1993 Churchill Livingstone, Edinburgh
4. British National Formulary (BNF) 1996 The Pharmaceutical Press, London, p 109
5. Consensus Development 1980 Thrombolytic therapy and treatment. British Medical Journal 280 1585-1587 cited in. Dollery C (ed) Streptokinase Therapeutic drugs. 1993 Churchill Livingstone, Edinburgh
6. Consensus Development 1980 Thrombolytic therapy and treatment. British Medical Journal 280 1585-1587 cited in. Dollery C (ed) Streptokinase Therapeutic drugs. 1993 Churchill Livingstone, Edinburgh
7. Crawford M 1995 Treatment of acute myocardial infarction Cardiology Climes Forward W B Saunders, Philadelphia
8. Davis M, Woolf N, Robertson W 1976 Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. British Heart Journal 38: 659-664 cited in. Horngan M, Topai E 1995 Direct angioplasy in acute myocardial infarction. Cardiology Clinics 13 (3): 321-338
9. Davis M, Woolf N, Robertson W 1976 Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. British Heart Journal 38: 659-664 cited in. Horngan M, Topai E 1995 Direct angioplasy in acute myocardial infarction. Cardiology Clinics 13 (3): 321-338
10. Department of Health 1992 The health of the nation. HMSO, London
11. Dollery C, ed 1993 Actilayse Therapeutic drugs Churchill Livingstone, Edinburgh
12. Elliot J M, Cross D B, Cederholm-Williams S A et al 1993 Neutralising antibodies to Streptokinase 4 years after IV thrombolytic therapy. American Journal of Cardiology 71 640-654
13. Fears R, Hearn J, Standring, et al 1992 Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous Streptokinase and antistreplase in acute myocardial infarction. American Heart Journal 124: 305-14
14. Fibriolytic Therapy Tnahsts Collaborative Group (FTTCG) 1994 Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet 343. 311-22
15. Gibbons R J, Holmes D R, Reeder G S et al 1993 Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction New England Journal of Medicine 328. 685-91 Cited in: Baker C 1994 Myocardial salvage in the ICU International Journal of Intensive Care 1 (4): 116-119
16. Gibbons R J, Holmes D R, Reeder G S et al 1993 Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction New England Journal of Medicine 328. 685-91 Cited in: Baker C 1994 Myocardial salvage in the ICU International Journal of Intensive Care 1 (4): 116-119
17. Grines C L, Nissen S E, Booth S E et al 1991 A prospective, non-randomised trial comparing combination halt dose rPA with streptokinase to full dose rPA. Circulation 84. 540-49